Biotech
Latest news, explainers and analysis on Biotech. Tracking 2 stories on Arth Vani.
Connected in the graph
Latest on Biotech
Moderna Stock: UBS Issues Rare 'Sell' Rating, Foresees 44% Price Drop
Investment bank UBS has issued a rare 'sell' rating on biotech firm Moderna, projecting a significant 44% decline in its stock price. This downgrade comes despite recent investor optimism surrounding Moderna's advancements in cancer vaccines, with UBS citing concerns over the company's valuation.
Indian Biotech Sector Booms as Startup Count Hits 2,400; PE Investments Double
India's pharmaceutical and biotech landscape is witnessing a massive shift with private equity investments doubling to $731 million. A new report highlights that the number of biotech startups has surged to 2,400, signaling a robust pipeline for new drug development.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.